MiR-194 suppresses metastasis of non-small cell lung cancer through regulating expression of BMP1 and p27 kip1

Oncogene

Volumn 33, Issue 12, 2014, Pages 1506-1514

  Wu, X ^a   Liu, T ^a   Fang, O ^a   Leach, L J ^b   Hu, X ^a   Luo, Z ^a,b  

^a FUDAN UNIVERSITY   (China)

^b UNIVERSITY OF BIRMINGHAM   (United Kingdom)

Author keywords

Metastasis; MiR 194; Non small cell lung cancer; Regulatory and signaling pathway; RhoA; TGFb

Indexed keywords

ACTIN; BETA CATENIN; CYCLIN DEPENDENT KINASE INHIBITOR 1B; GELATINASE A; GELATINASE B; MICRORNA; MICRORNA 194; PROCOLLAGEN C PROTEINASE; RHOA GUANINE NUCLEOTIDE BINDING PROTEIN; TRANSFORMING GROWTH FACTOR BETA; UNCLASSIFIED DRUG;

ACTIN FILAMENT; ANIMAL CELL; ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; ARTICLE; CANCER INHIBITION; CELL MIGRATION; CELL MOTILITY; CONTROLLED STUDY; DOWN REGULATION; EMBRYO; FEMALE; GENE EXPRESSION REGULATION; GENE OVEREXPRESSION; GENE REPRESSION; GENETIC ASSOCIATION; HUMAN; HUMAN CELL; INTRACELLULAR SIGNALING; LUNG METASTASIS; LUNG NON SMALL CELL CANCER; MOUSE; NONHUMAN; PRIORITY JOURNAL; TUMOR INVASION; WESTERN BLOTTING;

BASE SEQUENCE; BONE MORPHOGENETIC PROTEIN 1; CARCINOMA, NON-SMALL-CELL LUNG; CELL LINE, TUMOR; CELL MOVEMENT; CYCLIN-DEPENDENT KINASE INHIBITOR P27; GENE EXPRESSION REGULATION, NEOPLASTIC; HUMANS; LUNG NEOPLASMS; MICRORNAS; NEOPLASM INVASIVENESS; NEOPLASM METASTASIS;

EID: 84897056701     PISSN: 09509232     EISSN: 14765594     Source Type: Journal    
DOI: 10.1038/onc.2013.108     Document Type: Article

References (42)

1. Jemal A, Siegel R, Ward E, Hao Y, Xu J, Murray T et al. Cancer statistics. CA Cancer J Clin 2008; 58: 71-96.
2. Zhang S, Chen W, Kong L, Li L, Lu F, Li G et al. An analysis of cancer incidence and mortality from 30 cancer registries in China, 1998-2002. Bull Chin Cancer 2006; 16: 430-448.
3. D'Amico TA. Molecular biologic staging of lung cancer. Ann Thorac Surg 2008; 85: s737-s742.
4. Harpole DH. Prognostic modeling in early stage lung cancer: an evolving process from histopathology to genomics. Thorac Surg Clin 2007; 17: 67-73.
5. Gupta GP, Massague J. Cancer metastasis: building a framework. Cell 2006; 127: 679-695.
6. Fidler IJ. The pathogenesis of cancer metastasis: the 'seed and soil' hypothesis revisited. Nat Rev Cancer 2003; 3: 453-458.
7. Bartel DP. MicroRNAs: target recognition and regulatory functions. Cell 2009; 136: 215-233.
8. Garzon R, Croce CM. MicroRNAs in normal and malignant hematopoiesis. Curr Opin Hematol 2008; 15: 352-358.
9. Ventura A, Jacks T. MicroRNAs and cancer: short RNAs go a long way. Cell 2009; 136: 586-591.
10. Valastyan S, Reinhardt F, Benaich N, Calogrias D, Szasz AM, Wang ZC et al. A pleiotropically acting microRNA, miR-31, inhibits breast cancer metastasis. Cell 2009; 137: 1032-1064.
11. Valastyan S, Chang A, Benaich N, Reinhardt F, Weinberg RA. Activation of miR-31 function in already-established metastases elicits metastatic regression. Genes Dev 2011; 25: 646-659.
12. Kumar MS, Erkeland SJ, Pester RE, Chen CY, Ebert MS, Sharp PA et al. Suppression of non-small cell lung tumor development by the let-7 microRNA family. Proc Natl Acad Sci USA 2008; 105: 3903-3908.
13. Bommer GT, Gerin I, Feng Y, Kaczorowski AJ, Kuick R, Love RE et al. p53-mediated activation of miRNA 34 candidate tumor-suppressor genes. Curr Biol 2007; 17: 1298-1307.
14. Raver-Shapira N, Marciano E, Meiri E, Spector Y, Rosenfeld N, Moskovits N et al. Transcriptional activation of miR-34a contributes to p53-mediated apoptosis. Mol Cell 2007; 26: 731-743.
15. Xiong S, Zheng Y, Jiang P, Liu R, Liu X, Chu Y. MicroRNA-7 inhibits the growth of human non-small cell lung cancer A549 cells through targeting BCL-2. Int J Biol Sci 2011; 7: 805-814.
16. Hayashita Y, Osada H, Tatematsu Y, Yamada H, Yanagisawa K, Tomida S et al. A polycistronic microRNA cluster, miR-17-92, is overexpressed in human lung cancers and enhances cell proliferation. Cancer Res 2005; 65: 9628-9632.
17. Yanaihara N, Caplen N, Bowman E, Seike M, Kumamoto K, Yi M et al. Unique microRNA molecular profiles in lung cancer diagnosis and prognosis. Cancer Cell 2006; 9: 189-198.
18. Liu X, Sempere LF, Ouyang H, Memoli VA, Andrew AS, Luo Y et al. MicroRNA-31 functions as an oncogenic microRNA in mouse and human lung cancer cells by repressing specific tumor suppressors. J Clin Invest 2010; 120: 1298-1309.
19. Meng Z, Fu X, Chen X, Zeng S, Tian Y, Jove R et al. MiR-194 is a marker of hepatic epithelial cells and suppresses metastasis of liver cancer cells in mice. Hepatology 2010; 52: 2148-2157.
20. Pichiorri F, Suh SS, Rocci A, De Luca L, Taccioli C, Santhanam R et al. Downregulation of p53-inducible microRNAs 192, 194, and 215 impairs the p53/MDM2 autoregulatory loop in multiple myeloma development. Cancer Cell 2010; 18: 367-381.
21. Song Y, Zhao F, Wang Z, Liu Z, Chiang Y, Xu Y et al. Inverse association between miR-194 expression and tumor invasion in Gastric cancer. Ann Surg Oncol 2012; 19: S509-S517.
22. Dong P, Kaneuchi M, Watari H, Hamada J, Sudo S, Ju J et al. MicroRNA-194 inhibits epithelial to mesenchymal transition of endometrial cancer cells by targeting oncogene BMI-1. Mol Cancer 2011; 10: 99-107.
23. Aigner A. MicroRNAs (miRNAs) in cancer invasion and metastasis: therapeutic approaches based on metastasis-related miRNAs. J Mol Med 2011; 89: 445-457.
24. Pan TL, Wang PW, Huang CC, Yeh CT, Hu TH, Yu JS. Network analysis and proteomic identification of vimentin as a key regulator associated with invasion and metastasis in human hepatocellular carcinoma cells. J Proteomics 2012; 75: 4676-4692.
25. Wang JW, Peng SY, Li JT, Wang Y, Zhang ZP, Cheng Y et al. Identification of metastasis-associated proteins involved in gallbladder carcinoma metastasis by proteomic analysis and functional exploration of chloride intracellular channel 1. Cancer Lett 2009; 281: 71-81.
26. Chadrick ED, John SI, Carolyn ER, Francis GS. Epithelial to mesenchymal transition: the doorway to metastasis in human lung cancers. J Thorac Cardiov Sur 2010; 140: 505-513.
27. Wang JC, Su CC, Xu JB, Chen LZ, Hu XH, Wang GY et al. Novel microdeletion in the transforming growth factor b type II receptor gene is associated with giant and large cell variants of nonsmall cell lung carcinoma. Gene Chromosome Canc 2007; 46: 192-201.
28. Thiery JP. Epithelial-mesenchymal transitions in tumour progression. Nat Rev Cancer 2002; 2: 442-454.
29. Grimson A, Farh KK, Johnston WK, Garrett-Engele P, Lim LP, Bartel DP. MicroRNA targeting specificity in mammals: determinants beyond seed pairing. Mol Cell 2007; 27: 91-105.
30. Krek A, Grun D, Poy MN, Wolf R, Rosenberg L, Epstein EJ et al. Combinatorial microRNA target predictions. Nat Genet 2005; 37: 495-500.
31. Kruger J, Rehmsmeier M. RNAhybrid: microRNA target prediction easy, fast and flexible. Nucleic Acids Res 2006; 34: W451-W454.
32. Ge G, Greenspan DS. BMP1 controls TGFb1 activation via cleavage of latent TGFbbinding protein. J Cell Biol 2006; 175: 111-120.
33. Massague J. TGFb in cancer. Cell 2008; 134: 215-230.
34. Sehgal I, Thompson TC. Novel regulation of type IV collagenase (matrix metalloproteinase-9 and-2) activities by transforming growth factor-b 1 in human prostate cancer cell lines. Mol Biol Cell 1999; 10: 407-416.
35. Sicinski P, Zacharek S, Kim C. Daulity of p27kip1 function in tumorigenesis. Gene Dev 2007; 21: 1703-1706.
36. Besson A, Hwang HC, Cicero S, Donovan SL, Gurian-West M, Johnson D et al. Discovery of an oncogenic activity in p27kip1 that causes stem cell expression and a multiple tumor phenotype. Gene Dev 2007; 21: 1731-1746.
37. Kawauchi T, Chihama K, Nabeshima Y, Hoshino M. Cdk5 phosphorylates and stabilizes p27kip1 contributing to actin organization and cortical neuronal migration. Nat Cell Biol 2006; 8: 17-26.
38. Besson A, Gurian-West M, Schmidt A, Hall A, Roberts JM. p27kip1 modulates cell migration through the regulation of RhoA activation. Gene Dev 2004; 18: 862-876.
39. Ridley AJ, Hall A. The small GTP-binding protein rho regulates the assembly of focal adhensions and actin stress fibers in response to growth factors. Cell 1992; 70: 389-399.
40. Krutzfeldt J, Rosch N, Hausser J, Manoharan M, Zavolan M, Stoffel M. MicroRNA-194 is a target of transcription factor 1 Tcf, HNF1a in adult liver and controls expression of frizzled-6. Hepatology 2012; 55: 98-107.
41. Jenkins RH, Martin J, Phillips AO, Bowen T, Fraser D. Transforming growth factor beta-1 represses proximal tubular cell microRNA-192 expression via decreased Hepatocyte Nuclear Factor DNA binding. Biochem J 2012; 443: 407-416.
42. Ebert MS, Neilson JR, Sharp PA. MicroRNA sponges: competitive inhibitors of small RNAs in mammalian cells. Nat Methods 2007; 4: 721-726.